Drug-labels.com

Ran-Finasteride: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
5 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Ran-Finasteride

ABOUT THIS MEDICATION

RAN-FINASTERIDE IS FOR USE BY MEN ONLY.

What the medication is used for:

RAN-Finasteride is used to treat symptoms of benign prostatic hyperplasia (BPH) in men with an enlarged prostate. RAN-Finasteride may also be used to reduce the risk of developing a sudden inability to pass urine and the need for surgery.

RAN-Finasteride is not approved for the prevention of prostate cancer.

What it does:

RAN-Finasteride lowers levels of a key hormone called DHT (dihydrotestosterone), which is a major cause of prostate growth. Lowering DHT leads to shrinkage of the enlarged prostate gland in most men. This can lead to gradual improvement in urine flow and symptoms over the next several months. RAN-Finasteride will help reduce the risk of developing a sudden inability to pass urine (acute urinary retention) and the need for surgery.

When it should not be used:

Do not take RAN-Finasteride if you think you are allergic to any of its ingredients.

Women and children should not take RAN-Finasteride. Women who are or may potentially be pregnant must not use RAN-Finasteride (see WARNINGS AND PRECAUTIONS, Pregnancy).

What the medicinal ingredient is:

finasteride

What the important nonmedicinal ingredients are:

microcrystalline cellulose, hydroxyl propyl methyl cellulose, polyethylene glycol, coloring agents (FD&C blue 2 aluminum lake, titanium dioxide, iron oxide yellow), pregelatinized starch, lauroyl

macrogoglycerides, lactose monohydrate, magnesium stearate and sodium starch glycolate.

What dosage forms it comes in:

Each film coated tablet contains 5 mg of finasteride.

WARNINGS AND PRECAUTIONS

Pregnancy: Women who are or may potentially be pregnant must not use RAN-Finasteride. They should also not handle crushed or broken tablets of RAN-Finasteride. If the active ingredient in RAN-Finasteride is absorbed after oral use or through the skin by a woman who is pregnant with a male baby, it may cause the male baby to be born with abnormalities of the sex organs.

RAN-Finasteride are coated and will prevent contact with the active ingredient during normal handling provided that the tablets are not broken or crushed. If a woman who is pregnant comes into contact with the active ingredient in RAN-Finasteride, a physician should be consulted.

You must see your physician regularly while taking RAN-Finasteride. Follow your physician's advice about when to have these checkups.

About Prostate Specific Antigen (PSA). Your physician may have done a blood test called PSA for the screening of prostate cancer. RAN-Finasteride can alter PSA values. You should tell your physician that you are taking RAN-Finasteride USP. For more information, talk to your physician.

RAN-Finasteride may increase the chance of a more serious form of prostate cancer.

INTERACTIONS WITH THIS MEDICATION

Tell your physician or pharmacist about all the medicines you take. This includes prescription and non-prescription medicines, and herbal supplements.

PROPER USE OF THIS MEDICATION

Take RAN-Finasteride as your physician has prescribed.

Usual dose:

5 mg tablet once daily by mouth with or without food

Missed dose:

If you miss a dose, do not take an extra one. Just take the next tablet as usual.

IMPORTANT:PLEASE READ

IMPORTANT:PLEASE READ

Consumer Information – RAN-Finasteride Page 27 of 27

Overdose:

In case of drug overdose, contact a health care

practitioner, hospital emergency department or

regional Poison Control

Centre immediately, even if there are no symptoms.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Like any medicine, RAN-FINASTERIDE may cause side effects. Side effects due to RAN-Finasteride 5 mg may include

  • impotence (an inability to have an erection)
  • less desire to have sex.
  • problems with ejaculation, such as a decrease in

    the amount of semen released during sex.

In addition, some men may have breast swelling and/or tenderness. Some men have also reported the following:

  • allergic reactions such as rash, itching, hives and

    swelling of the lips and face

  • testicular pain.
  • an inability to have an erection that continued after

    stopping the medication

  • male infertility and/or poor quality of semen.
  • Improvement in the quality of semen has been

    reported after stopping the medication.

  • depression
  • decrease in sex drive that continued after stopping the

    medication.

In rare cases, male breast cancer has been reported.

You should promptly report to your physician any changes in your breasts such as lumps, pain or nipple discharge.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY
HAPPEN
AND WHAT TO DO ABOUT THEM
Symptoms / EffectsTalk with your physician or pharmacist

Stop

taking drug and seek

immediate emergency medical attention

Only if severeIn all cases
RareAllergic reactions including rash, hives, and swelling of the lips and face.√

This is not a complete list of side effects. For any unexpected effects while taking RAN-Finasteride , contact your physician or pharmacist.

HOW TO STORE IT

Store at room temperature (15°C-30°C) and protect from light.

KEEP RAN-FINASTERIDE AND ALL MEDICINES OUT OF THE REACH OF CHILDREN.

This document plus the full product monograph, prepared for health professionals can be obtained by contacting the sponsor

Ranbaxy Pharmaceuticals Canada Inc. at: 1-866-840-1340

Pharmaceuticals Canada Inc

Last revised: January 8, 2013

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

  • Report online at

    www.healthcanada.gc.ca/medeffect

  • Call toll-free at 1-866-234-2345
  • Complete a Canada Vigilance Reporting Form and:

    • Fax toll-free to 1-866-678-6789, or
    • Mail to: CanadaVigilance Program

      Health Canada

      Postal Locator 0701D

      Ottawa ON K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffectTM Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02371820

Revision date stated in the text: January 8, 2013

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Ran-Finasteride

Rx or OTC
Prescription (Rx)?
DIN 02371820
Schedule(s) PRESCRIPTION
Active ingredient(s) Finasteride 5 MG
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. G Genito urinary system and sex hormones
    1. G04 Urologicals
      1. G04C Drugs used in benign prostatic hypertrophy
        1. G04CB Testosterone-5-alpha reductase inhibitors for benign prostatic hypertrophy
          1. G04CB01 Finasteride
Company RANBAXY PHARMACEUTICALS CANADA INC.
Current status Cancelled Post Market
Current status date March 30, 2022

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.